NCT01177241已完成不适用
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10,000
研究概览
简要总结
Using a retrospective analysis of a large commercial claims database and a Medicare database, the investigators evaluated DDEs that have the potential to cause DDIs among chronic low back pain (cLBP) patients on long-term opioid analgesia, which metabolizes through the CYP450 enzyme system, concomitant with other CYP450-metabolized drug(s)
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •chronic low back pain
排除标准
- •pregnancy
研究者
Joseph Pergolizzi, MD
Principal Investigator
NEMA Research, Inc.
相似试验
已完成
不适用
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple PrescriptionsChronic Low Back PainNCT01177254NEMA Research, Inc.10,000
已完成
不适用
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions(DDI) Among Osteoarthritis PatientsOsteoarthritisNCT01177267NEMA Research, Inc.10,000
已完成
不适用
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic OutcomesChronic Low Back PainNCT01177280NEMA Research, Inc.10,000
已完成
1 期
A Study to Assess the Effects of Itraconazole and Rifampin on Lazertinib in Healthy Adult ParticipantsHealthyNCT04410094Janssen Research & Development, LLC32
已完成
4 期
Pharmacogenetic and Pharmacokinetics of Naproxen and Associated Naproxen-esomeprazolePoor Metabolizer Due to Cytochrome P450 CYP2C9 VariantPoor Metabolizer Due to Cytochrome p450 CYP2C19 VariantNCT03092193University of Sao Paulo8